Tagged with Hong Kong,

Hong Kong With Hong Kong now established as the world’s second largest funding hub for biotech, at this week’s BIO 2019 conference in Philadelphia, the HKEX’s Michael Chan outlined some of the successes that the Hong Kong exchange has already seen and the exciting and diverse future listings in the pipeline.  …

Biotech Hong Kong is now the world’s second largest funding hub for biotech according to Hong Kong Chief Executive Carrie Lam. During her speech at the 2nd HKEx Biotech Summit on May 29, Lam stated that innovation and technology have become a clear priority in government policy.   We have invested…

China Cash has always ruled the start-up world and when it comes to the healthcare and life sciences sphere, the heavy investment required for R&D and the long timelines make it even more so. Luckily, China is now the second-largest VC market in the world, and a recent Preqin report highlighted that USD 65…

Hong Kong Energetically touting itself as “Asia’s World City” as well as a connector between East and West with its inextricable links to both mainland China and the international community, Hong Kong is today seeking to augment her position as a global financial center by transforming herself into a biotech and biomedical…

Hong Kong Yvette Chu, general manager of CooperVision Hong Kong, shares the affiliate’s double-digit growth over the past three years, the importance of their relationships with the optometrists in Hong Kong, the value of their innovative and comprehensive portfolio of contact lenses, and her vision for the affiliate in the next few…

China In 2013, Chinese President Xi Jinping launched the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) initiative, corralling the two Special Administrative Regions (SARs) of Hong Kong and Macao with Guangdong, one of the richest of China’s 34 provinces. While the official government blueprint was due to be unveiled in mid-2018, escalating…

Hong Kong Ray Huang of Silicon Valley consultancy Exponent gives his first impressions of Hong Kong as well as discussing fostering innovation and retaining talent in Asia.   Following your recent move from Silicon Valley, what are your impressions of Hong Kong so far? What stands out the most about Hong Kong…

Hong Kong Tim Collins of DCH Auriga outlines the Asia-Pacific healthcare distribution landscape, DCH’s expansion plans and what Hong Kong offers as a regional headquarters.   After 14 years with LF Asia, you joined DCH and were actively involved in the recent acquisition. What are the key learnings that you are bringing…

Hong Kong Ricky Chiu of Phase Scientific International discusses exciting new technological developments in the diagnostic field and the benefits of being based in Hong Kong.   Having founded PHASE Scientific in America in 2012, what was the motive behind moving its operations to Asia, and why Hong Kong specifically? There are…

Hong Kong Bobby Liu of Milton Holdings International outlines the company’s evolution in the plastics and packaging industry and the specialized services it provides to clients in medtech and pharmaceuticals.   What is the story behind the creation of the company and how did you find such a niche in the market?…

Hong Kong Laurence Frémy, director for APAC at Laboratoires Expanscience, discusses emerging skincare and dermatology trends in the region and her priorities for the affiliate.   Having had the experience of opening the affiliate in Brazil, in addition to your in-depth understanding of other emerging markets, what were the key skills you…

Hong Kong Zuellig Pharma’s Andi Umbricht discusses the distributor’s deep commitment to Asia, the adoption of new technologies, and emerging trends within the Hong Kong and Asian distribution markets. Zuellig Pharma has a long tradition in Asia. What capabilities have you developed over the years in the region? Zuellig Pharma started operations…